HRB National Drugs Library e-newsletter volume 18, issue 10

In this issue

International publications

Data from the UNODC early warning advisory on new psychoactive substances.

(2022) United Nations Office on Drugs and Crime.

Outreach programs to improve life circumstances and prevent further adverse developmental trajectories of at-risk youth in OECD countries.

Filges, Trine et al (2022) Campbell Systematic Reviews, 18, (4).

Addictive and other mental disorders: a call for a standardized definition of dual disorders.

Szerman, Nestor et al (2022) Translational Psychiatry, 12. doi: 10.1038/s41398-022-02212-5

Invisible numbers: the true extent of noncommunicable diseases and what to do about them.

(2022) Geneva: World Health Organization.

Harm Reduction Database Wales: drug related mortality annual report 2021-22.

Public Health Wales, Communicable Disease Surveillance Centre. (2022) Cardiff: Public Health Wales.

IOAD 2022 conference [Videos] - Driving change: improving policy and practice to prevent drug deaths.

(2022) Scottish Drugs Forum.

A review of immunotherapeutic approaches for substance use disorders: current status and future prospects

Celik, Muhammet and Fuehrlein, Brian (2022) ImmunoTargets and Therapy, 11. pp. 55-66. doi: 10.2147/ITT.S370435

2022 NDARC annual research symposium: spotlight presentations.

(2022) Sydney: NDARC.

The impact of the COVID-19 pandemic on addictive disorders-an update.

Marsden, John et al (2022) Addiction, 117, (11), pp. 2762-2766. doi: 10.1111/add.16033

Submission to OHCHR for the High Commissioner’s report on human rights implications of and good practices and key challenges of equitable and universal access to and distribution of COVID-19 vaccines.

Harm Reduction International, Prison Reform International. (2022) London: Harm Reduction International.

A qualitative systematic review of access to substance use disorder care in the United States criminal justice system.

Barenie, Rachel E et al (2022) International Journal of Environmental Research and Public Health, 19, (19), 12647. doi: 10.3390/ijerph191912647

College student Fear of Missing Out (FoMO) and maladaptive behavior: Traditional statistical modeling and predictive analysis using machine learning.

McKee, Paul C et al (2022) PLoS ONE, 17, (10).

The targeted analysis of new psychoactive substances in oral fluid through chromatographic-spectrometric methods: review of recent findings.

Di Trana, A et al (2022) European Review for Medical and Pharmacological Sciences, 26, (3), pp. 750-754.

Reports of adverse events associated with use of novel psychoactive substances, 2017–2020: a review.

Mohr, Amanda L A et al (2022) Journal of Analytical Toxicology, 46, (6), e116-e185. doi: 10.1093/jat/bkac023

Processes and progress of civil society monitoring of new drugs trends.

(2022) Amsterdam: Correlation – European Harm Reduction Network

Map of the current application of quality standards in the area of prevention in EU countries results from FENIQS-EU project.

Ferić, Martina et al (2022) FENIQS EU

Rapid Action Drug Alerts and Response (RADAR) quarterly report.

(2022) Public Health Scotland.

The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS.

Pulver, Benedikt et al (2022) Drug Testing and Analysis, 14, (8), pp. 1491-1502. doi: 10.1002/dta.3280

Current NPS threats: volume V.

(2022) Vienna: United Nations Office on Drugs and Crime.

Evaluating a tool to improve engagement and recruitment of under-served groups in trials.

Morris, Lydia et al (2022) Trials, 23. doi: 10.1186/s13063-022-06747-2

Moving towards a continuum of safer supply options for people who use drugs: a qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.

Foreman-Mackey, Annie et al (2022) Substance Abuse Treatment, Prevention, and Policy, 17. doi: 10.1186/s13011-022-00494-y

Moral injury in the context of substance use disorders: a narrative review.

Van Denend, Jessica et al (2022) Current Treatment Options in Psychiatry, Early online. pp. 1-10. doi: 10.1007/s40501-022-00280-4

A mechanistic overview of approaches for the treatment of psychostimulant dependence.

Jensen, Kathrine Louise et al (2022) Frontiers in Pharmacology, 13. doi: 10.3389/fphar.2022.854176

Evaluation of early ketamine effects on belief-updating biases in patients with treatment-resistant depression.

Bottemanne, Hugo et al (2022) JAMA Psychiatry, Early online.

Examining the gender dimension in the non-medical use of over the counter and prescription only medication.

Gittins, Rosalind et al (2022) Drug Science, Policy and Law, 8. doi.org/10.1177/20503245221132548

Interventions for integrating behavioral health services into HIV clinical care: a narrative review.

Goldhammer, Hilary et al (2022) Open Forum Infectious Diseases, 9, (8). doi: 10.1093/ofid/ofac365

Interventions to prevent HIV and Hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020).

Palmateer, Norah E et al (2022) International Journal of Drug Policy, 109.

Opioid misuse: a review of the main issues, challenges, and strategies.

Biancuzzi, Helena et al (2022) International Journal of Environmental Research and Public Health, 19, (18). doi: 10.3390/ijerph191811754

Examining access to primary care for people with opioid use disorder in Ontario, Canada: a randomized clinical trial.

Spithoff, Sheryl et al (2022) JAMA Network Open, 5, (9). doi: 10.1001/jamanetworkopen.2022.33659

Burden and treatment of chronic obstructive pulmonary disease among people using illicit opioids: matched cohort study in England.

Lewer, Dan et al (2022) BMJ Medicine, 1. doi: 10.1136/bmjmed-2022-000215

Epigenetic modulation of opioid receptors by drugs of abuse.

Reid, Ke Zhang et al (2022) International Journal of Molecular Sciences, 23, (19), 11804. doi: 10.3390/ijms231911804

The Drug Science podcast #73. Overdose prevention centres.

Nutt, David et al (2022) London: Drug Science.

'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.

Filteau, Matthew R et al (2022)Harm Reduction Journal, 19, (1),

MAT standard 1 - Towards implementation: The MAT standards webinar series.

(2022) Edinburgh: Scottish Drugs Forum

The North American opioid crisis: how effective are supervised consumption sites?

Kennedy, Mary Clare et al (2022) The Lancet, 400, (10361), pp. 1403-1404

Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic.

Frost, Madeline C et al (2022) JAMA Network Open, 5, (10).

Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.

Bozinoff, Nikki et al (2022) Harm Reduction Journal, 19. doi: 10.1186/s12954-022-00695-5

Medical cannabis legalisation in Europe: where are we now and which countries should you be watching?

Richards, Monica (2022) Cannabis Industry News

The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury

Boakye, Ellen et al (2022) PLoS ONE, 17, (10).

Association of cannabis use during pregnancy with severe acute respiratory syndrome coronavirus 2 infection: a retrospective cohort study.

Young-Wolff, Kelly C et al (2022) Addiction, Early online. https://doi.org/10.1111/add.16056

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis

Argote, Mathilde et al (2022) Schizophrenia, 8, (1). doi: 10.1038/s41537-022-00286-0

The who and how of attentional bias in cannabis users: associations with use severity, craving and interference control.

Kroon, Emese et al (2022) Addiction, Early online. https://doi.org/10.1111/add.16059

Cannabis use and public health: time for a comprehensive harm-to-others framework.

Fischer, Benedikt et al (2022) The Lancet. Public health, 7, (10), e808-e809

Synthetic cannabinoids and cannabis: how the patterns of use differ: results from the European web survey on drugs.

López-Pelayo, Hugo et al (2022) International Journal of Mental Health and Addiction, Early online. doi.org/10.1007/s11469-022-00919-6

Effect of a novel brief motivational intervention for alcohol-intoxicated young adults in the emergency department: a randomized clinical trial.

Gaume, Jacques et al (2022) JAMA Network Open, 5, (10).

Leveraging mhealth and wearable sensors to manage alcohol use disorders: a systematic literature review

Kruse, Clemens Scott et al (2022) Healthcare, 10, (9).

Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: protocol for a systematic review of longitudinal studies

Powell, Anna et al (2022) PLoS ONE, 17, (9). doi: 10.1371/journal.pone.0274752

Alcohol price floors and externalities: the case of fatal road crashes

Francesconi, Marco and James, Jonathan (2022) Journal of Policy Analysis and Management, Early online. https://doi.org/10.1002/pam.22414

The emperor has no clothes: a synthesis of findings from the Transformative Research on the Alcohol industry, Policy and Science research programme

McCambridge, Jim et al (2022) Addiction, Early online. doi: 10.1111/add.16058

Alcohol health warning labels: a rapid review with action recommendations

Giesbrecht, Norman et al (2022) International Journal of Environmental Research and Public Health, 19, (18).

"Doctor, can I drink an alcohol-free beer?" Low-alcohol and alcohol-free drinks in people with heavy drinking or alcohol use disorders: systematic review of the literature

Caballeria, Elsa et al (2022) Nutrients, 14, (19), 3925. doi: 10.3390/nu14193925

Alcohol minimum unit pricing and people experiencing homelessness: a qualitative study of stakeholders' perspectives and experiences

Dimova, Elena D et al (2022) Drug and Alcohol Review, Early online. https://doi.org/10.1111/dar.13548

Contributing to licensing policy reviews: a guide for local stakeholders.

(2022) Glasgow: Alcohol Focus Scotland.

Tackling risk factors for non-communicable diseases: the pros and cons of a more integrated approach.

Smokefree Action Coalition, Obesity Health Alliance, Alcohol Health Alliance. (2022) Edinburgh: SPECTRUM Consortium.

Impact of vaping prevention advertisements on US adolescents: a randomized clinical trial.

Noar, Seth M et al (2022) JAMA Network Open, 5, (10). https://doi.org/10.1001/jamanetworkopen.2022.36370

Second-hand smoke exposure among Home Care Workers (HCWs) in Scotland.

Dobson, Ruaraidh et al (2022) Annals of Work Exposures and Health, Early online. https://doi.org/10.1093/annweh/wxac066

Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model.

Jones, Matthew et al (2022) Addiction, 117, (11), pp. 2907-2917. doi: 10.1111/add.15968

Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial.

Hajek, Peter et al (2022) Nature Medicine, 28, (5), pp. 958-964

Biomarkers of potential harm in people switching from smoking tobacco to exclusive e-cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e-cigarettes for smoking cessation.

Hartmann-Boyce, Jamie et al (2022) Addiction, Early online. doi: 10.1111/add.16063

How do I know if I have a gambling disorder?

In: Breaking free: how to stop gambling. Bowden-Jones, Henrietta and Leonidaki, Venetia, eds. Geel, Andre (2022) Cambridge University Press. pp. 10-19

Excessive smartphone use and addiction: when harms start outweighing benefits.

Larsen, Helle et al (2022) Addiction, Early online. https://doi.org/10.1111/add.16060

Association of cyberbullying and internet use disorder.

Floros, Georgios and Mylona, Ioanna (2022) Current Addiction Reports, Early online, pp. 1-14. doi: 10.1007/s40429-022-00440-9

Copyright © 2022 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on alcohol and other drugs research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries. Not sure what we can do for you? Email us and we will be happy to discuss your information needs.